Managing a nosocomial outbreak of carbapenem-resistant Klebsiella pneumoniae: An early Australian hospital experience

Internal Medicine Journal

Volumn 45, Issue 10, 2015, Pages 1037-1043

  Chang, Lisa W K ^a   Buising, K L ^b,c   Jeremiah, C J ^c   Cronin, K ^c   Poy Lorenzo, Y S ^c   Howden, B P ^b   Kwong, J ^b   Cocks, J ^c   Blood, A ^c   Greenough, J ^c   Waters, M J ^c  

^a Dorevitch Pathology   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c ST VINCENT S HOSPITAL   (Australia)

Author keywords

Antimicrobial resistance; Carbapenemase; Klebsiella pneumoniae; KPC

Indexed keywords

AMIKACIN; BETA LACTAMASE; CIPROFLOXACIN; GENTAMICIN; MEROPENEM; NORFLOXACIN; TOBRAMYCIN; ANTIINFECTIVE AGENT; BETA-LACTAMASE KPC-2; CARBAPENEM DERIVATIVE;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; AUSTRALIA; BACTERIAL GENE; BACTERIUM DETECTION; BACTERIUM ISOLATE; CARBAPENEM RESISTANT KLEBSIELLA PNEUMONIAE; CLINICAL ARTICLE; EPIDEMIC; FEMALE; HOSPITAL INFECTION; HOSPITAL PATIENT; HUMAN; INFECTION CONTROL; KLEBSIELLA PNEUMONIAE; KPC 2 GENE; MALE; MIDDLE AGED; MOLECULAR TYPING; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; VERY ELDERLY; YOUNG ADULT; CROSS INFECTION; EPIDEMIOLOGY; GENETICS; HOSPITAL MORTALITY; ISOLATION AND PURIFICATION; KLEBSIELLA INFECTIONS; MICROBIAL SENSITIVITY TEST;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; AUSTRALIA; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CARBAPENEMS; CROSS INFECTION; DISEASE OUTBREAKS; FEMALE; HOSPITAL MORTALITY; HUMANS; INFECTION CONTROL; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84942915923     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/imj.12863     Document Type: Article

References (25)

1. da Silva RM, Traebert J, Galato D. Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae: a review of epidemiological and clinical aspects. Expert Opin Biol Ther 2012; 12: 663-671.
2. Patel G, Huprikar S, Factor SH, Jenkins SG, Calfee DP. Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect Control Hosp Epidemiol 2008; 29: 1099-1106.
3. Yigit H, Queenan AM, Anderson GJ, Domenech-Sanchez A, Biddle JW, Steward CD etal. Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother 2001; 45: 1151-1161.
4. Bush K, Jacoby GA. Updated functional classification of beta-lactamases. Antimicrob Agents Chemother 2010; 54: 969-976.
5. Palmore TN, Henderson DK. Managing transmission of carbapenem-resistant enterobacteriaceae in healthcare settings: a view from the trenches. Clin Infect Dis 2013; 57: 1593-1599.
6. Schwaber MJ, Klarfeld-Lidji S, Navon-Venezia S, Schwartz D, Leavitt A, Carmeli Y. Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality. Antimicrob Agents Chemother 2008; 52: 1028-1033.
7. Souli M, Galani I, Antoniadou A, Papadomichelakis E, Poulakou G, Panagea T etal. An outbreak of infection due to beta-Lactamase Klebsiella pneumoniae Carbapenemase 2-producing K. pneumoniae in a Greek University Hospital: molecular characterization, epidemiology, and outcomes. Clin Infect Dis 2010; 50: 364-373.
8. Balm MN, Ngan G, Jureen R, Lin RT, Teo J. Molecular characterization of newly emerged blaKPC-2-producing Klebsiella pneumoniae in Singapore. J Clin Microbiol 2012; 50: 475-476.
9. Chua KYL, Grayson ML, Burgess AN, Lee JYH, Howden BP. The growing burden of multidrug resistant infections among returned Australian travellers. Med J Aust 2014; 200: 116-118.
10. Coatsworth NR, Huntington PG, Hardiman RP, Hudson BJ, Fernandes CJ. A case of carbapenemase-producing Klebsiella pneumoniae in Australia. Pathology 2012; 44: 42-44.
11. Clinical Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing. CLSI Document M100-S22. Wayne, PA: Clinical Laboratory Standards Institute; 2012.
12. Endimiani A, Carias LL, Hujer AM, Bethel CR, Hujer KM, Perez F etal. Presence of plasmid-mediated quinolone resistance in Klebsiella pneumoniae isolates possessing blaKPC in the United States. Antimicrob Agents Chemother 2008; 52: 2680-2682.
13. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH etal. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995; 33: 2233-2239.
14. Kotsanas D, Wijesooriya WR, Korman TM, Gillespie EE, Wright L, Snook K etal. 'Down the drain': carbapenem-resistant bacteria in intensive care unit patients and handwashing sinks. Med J Aust 2013; 198: 267-269.
15. Starlander G, Melhus A. Minor outbreak of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in an intensive care unit due to a contaminated sink. J Hosp Infect 2012; 82: 122-124.
16. Snitkin ES, Zelazny AM, Thomas PJ, Stock F, Henderson DK, Palmore TN etal. Tracking a hospital outbreak of carbapenem-resistant Klebsiella pneumoniae with whole-genome sequencing. Sci Transl Med 2012; 4: 148ra16.
17. Casewell M, Phillips I. Hands as route of transmission for Klebsiella species. Br Med J 1977; 2: 1315-1317.
18. Center of Disease Control and Prevention. CRE toolkit - guidance for control of carbapenem-resistant Enterobacteriaceae. 2012 [cited 2012 November 2]. Available from URL: http://www.cdc.gov/hai/organisms/cre/cre-toolkit/
19. Pasteran F, Lucero C, Soloaga R, Rapoport M, Corso A. Can we use imipenem and meropenem Vitek 2 MICs for detection of suspected KPC and other-carbapenemase producers among species of Enterobacteriaceae? J Clin Microbiol 2011; 49: 697-701.
20. Doern CD, Dunne WM Jr, Burnham CA. Detection of Klebsiella pneumoniae carbapenemase (KPC) production innon-Klebsiella pneumoniae Enterobacteriaceae isolates by use of the Phoenix, Vitek 2, and disk diffusion methods. J Clin Microbiol 2011; 49: 1143-1147.
21. Tenover FC, Kalsi RK, Williams PP, Carey RB, Stocker S, Lonsway D etal. Carbapenem resistance in Klebsiella pneumoniae not detected by automated susceptibility testing. Emerg Infect Dis 2006; 12: 1209-1213.
22. Nordmann P, Poirel L, Dortet L. Rapid detection of carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis 2012; 18: 1503-1507.
23. Australian Commission on Safety and Quality in Health Care. Recommendations for the Control of Multi-Drug Resistant Gram Negatives. Sydney: AQSQHC; 2013.
24. Bulik CC, Nicolau DP. Double-carbapenem therapy for carbapenemase-producing Klebsiella pneumoniae. Antimicrob Agents Chemother 2011; 55: 3002-3004.
25. Karaiskos I, Masgala A, Galani L, Baziaka F, Giamarellou H Double-carbapenem regimens for infections in humans due to carbapenemase-producing Klebsiella pneumoniae. Interscience Conference on Antimicrobial Agents and Chemotherapy; September 10-13; Denver, CO2013; 2013.